157 related articles for article (PubMed ID: 12064481)
1. Peptidylarginine deiminase: a candidate factor in demyelinating disease.
Moscarello MA; Pritzker L; Mastronardi FG; Wood DD
J Neurochem; 2002 Apr; 81(2):335-43. PubMed ID: 12064481
[TBL] [Abstract][Full Text] [Related]
2. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.
Musse AA; Li Z; Ackerley CA; Bienzle D; Lei H; Poma R; Harauz G; Moscarello MA; Mastronardi FG
Dis Model Mech; 2008; 1(4-5):229-40. PubMed ID: 19093029
[TBL] [Abstract][Full Text] [Related]
4. Deimination of myelin basic protein. 2. Effect of methylation of MBP on its deimination by peptidylarginine deiminase.
Pritzker LB; Joshi S; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5382-8. PubMed ID: 10820009
[TBL] [Abstract][Full Text] [Related]
5. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.
Mastronardi FG; Mak B; Ackerley CA; Roots BI; Moscarello MA
J Clin Invest; 1996 Jan; 97(2):349-58. PubMed ID: 8567954
[TBL] [Abstract][Full Text] [Related]
6. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.
Pritzker LB; Joshi S; Gowan JJ; Harauz G; Moscarello MA
Biochemistry; 2000 May; 39(18):5374-81. PubMed ID: 10820008
[TBL] [Abstract][Full Text] [Related]
7. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
[TBL] [Abstract][Full Text] [Related]
8. Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent.
Mastronardi FG; Ackerley CA; Roots BI; Moscarello MA
J Neurosci Res; 1996 May; 44(4):301-7. PubMed ID: 8739149
[TBL] [Abstract][Full Text] [Related]
9. Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain.
Lamensa JW; Moscarello MA
J Neurochem; 1993 Sep; 61(3):987-96. PubMed ID: 7689646
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase activity in postmortem white matter of patients with multiple sclerosis.
De Keyser J; Schaaf M; Teelken A
Neurosci Lett; 1999 Jan; 260(1):74-6. PubMed ID: 10027703
[TBL] [Abstract][Full Text] [Related]
11. Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere.
Akiyama K; Sakurai Y; Asou H; Senshu T
Neurosci Lett; 1999 Oct; 274(1):53-5. PubMed ID: 10530518
[TBL] [Abstract][Full Text] [Related]
12. Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system.
Seiwa C; Sugiyama I; Yagi T; Iguchi T; Asou H
Neurosci Res; 2000 May; 37(1):21-31. PubMed ID: 10802341
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNAs located in myelin sheath assembly sites.
Gould RM; Freund CM; Palmer F; Feinstein DL
J Neurochem; 2000 Nov; 75(5):1834-44. PubMed ID: 11032872
[TBL] [Abstract][Full Text] [Related]
14. The developmental expression and activity of peptidylarginine deiminase in the mouse.
Pritzker LB; Nguyen TA; Moscarello MA
Neurosci Lett; 1999 May; 266(3):161-4. PubMed ID: 10465698
[TBL] [Abstract][Full Text] [Related]
15. Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Yang L; Tan D; Piao H
Neurochem Res; 2016 Aug; 41(8):1845-56. PubMed ID: 27097548
[TBL] [Abstract][Full Text] [Related]
16. Myelin Basic Protein Citrullination, a Hallmark of Central Nervous System Demyelination, Assessed by Novel Monoclonal Antibodies in Prion Diseases.
Jang B; Jeon YC; Shin HY; Lee YJ; Kim H; Kondo Y; Ishigami A; Kim YS; Choi EK
Mol Neurobiol; 2018 Apr; 55(4):3172-3184. PubMed ID: 28470584
[TBL] [Abstract][Full Text] [Related]
17. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis.
Moscarello MA; Mastronardi FG; Wood DD
Neurochem Res; 2007 Feb; 32(2):251-6. PubMed ID: 17031564
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.
Jang B; Kim E; Choi JK; Jin JK; Kim JI; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Am J Pathol; 2008 Oct; 173(4):1129-42. PubMed ID: 18787103
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Moscarello MA; Lei H; Mastronardi FG; Winer S; Tsui H; Li Z; Ackerley C; Zhang L; Raijmakers R; Wood DD
Dis Model Mech; 2013 Mar; 6(2):467-78. PubMed ID: 23118341
[TBL] [Abstract][Full Text] [Related]
20. A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain.
Pritzker LB; Moscarello MA
Biochim Biophys Acta; 1998 Oct; 1388(1):154-60. PubMed ID: 9774721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
